Morgan Stanley Bio Techne Corp Put Options Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TECH
# of Institutions
611Shares Held
149MCall Options Held
213KPut Options Held
56.9K-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.39 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15MShares$1.14 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.42MShares$716 Million0.09% of portfolio
-
State Street Corp Boston, MA6.4MShares$486 Million0.02% of portfolio
-
Bamco Inc New York, NY4.45MShares$338 Million0.97% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.98B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...